Efficace, Fabio ORCID: https://orcid.org/0000-0002-5065-5166; Mahon, Francois-Xavier; Richter, Johan ORCID: https://orcid.org/0000-0002-0374-6823; Piciocchi, Alfonso ORCID: https://orcid.org/0000-0001-8648-885X; Cipriani, Marta ORCID: https://orcid.org/0000-0001-6159-8059; Nicolini, Franck E.; Mayer, Jiri; Zackova, Daniela ORCID: https://orcid.org/0000-0001-9802-8148; Janssen, Jeroen J. W. M. ORCID: https://orcid.org/0000-0001-9567-1955; Panayiotidis, Panayiotis; Vestergaard, Hanne; Koskenvesa, Perttu; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Martinez-Lopez, Joaquin; Olsson-Strömberg, Ulla; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Berger, Marc G.; Etienne, Gabriel; Klamova, Hana ORCID: https://orcid.org/0009-0000-5020-7040; Faber, Edgar; Rousselot, Philippe; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690 und Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2024):
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
In: Leukemia, Bd. 38, Nr. 8: S. 1722-1730
Volltext auf 'Open Access LMU' nicht verfügbar.
- Dokument bearbeiten